7 Undervalued Pharmaceuticals Stocks for Wednesday, October 30
Discover the top 7 undervalued Pharmaceuticals stocks for Wednesday, October 30 based on AAII’s Stock Grades.Tudor Pop
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
IM Cannabis Corp. engages in importation, distribution and sale of medical cannabis products in Israel and Germany. It provides medical cannabis dried flowers; and full-spectrum cannabis extracts under the IMC, BLKMT, and LOT420 brands. The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Vancouver, Canada.
Commentary & Analysis
3 Undervalued Retailers - Drug Stocks for Monday, September 09
Discover the top 3 undervalued Retailers - Drug stocks for Monday, September 09 based on AAII’s Stock Grades.Eunice Kim
3 Undervalued Retailers - Drug Stocks for Wednesday, August 07
Discover the top 3 undervalued Retailers - Drug stocks for Wednesday, August 07 based on AAII’s Stock Grades.Jenna Brashear
3 Undervalued Pharmaceuticals Stocks for Monday, May 13
Discover the top 3 undervalued Pharmaceuticals stocks for Monday, May 13 based on AAII’s Stock Grades.Eunice Kim
5 Undervalued Pharmaceuticals Stocks for Monday, April 01
Discover the top 5 undervalued Pharmaceuticals stocks for Monday, April 01 based on AAII’s Stock Grades.Jenna Brashear
Financial Summary
| Share Statistics | IMCC | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $1.5 | $496.7 | 1% |
|
| Shares Out (Mil) | 0.2 | 42.8 | 2% |
|
| Institutional Ownership | 5.2% | 81.2% | 5% |
|
| Float (Mil) | 1.1 | 44.5 | 3% |
|
| Beta | 2.21 | 0.72 | 93% |
|
| Avg Daily Volume (000s) | 80 | 268 | 34% |
|
| Price Change (52-week) |
(97.8%) | 56.1% | 2% |
|
| Growth | IMCC | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 26.1% | 6.4% | 87% |
|
| Net Income (5yr) | 18.1% | (2.0%) | 70% |
|
| EPS (5yr) | 26.3% | 15.0% | 77 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | 17.3% | (15.1%) | 76% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | IMCC | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $32 | $392 | 16% |
|
| Net Income (TTM) (Mil) | ($13) | ($11) | 27% |
|
| EPS (TTM) | ($57.940) | ($0.700) | 1% |
|
| Operating Cash Flow (TTM) (Mil) | $-0 | ($7) | 32% |
|
| Net Cash Flow (TTM) (Mil) | $1 | $3 | 45% |
|
| Long-Term Debt (Q1) (Mil) | $1 | $6 | 15% |
|
| Enterprise Value (Q1) (Mil) | $10 | $493 | 8% |
|
| Valuation | IMCC | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 2.23 | na |
|
| P/E | na | 17.4 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.2 | na |
|
| Ratios | IMCC | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 12.5% | 67.8% | 12% |
|
| Net Margin | (39.1%) | 3.3% | 13% |
|
| ROA | (53.1%) | (22.0%) | 11% |
|
| ROE | na | (20.6%) | na |
|
| Liabilities to Assets | 122.8% | 32.0% | 97% |
|
| F-Score | 3 | 3 | 18% |
|
IM Cannabis Corp. did not pass any screens on 10/29/2026.
